Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance (Usage Results Study) of Azilsartan Medoxomil/Chlorthalidone FDC in the Treatment of Patients With Essential Hypertension in South Korea

NCT04470830 is registered in ClinicalTrials.gov with Celltrion Pharm, Inc. as lead sponsor.

NCT NCT04470830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04470830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance (Usage Results Study) of Azilsartan Medoxomil/Chlorthalidone FDC in the Treatment of Patients With Essential Hypertension in South Korea
Lead sponsor
Celltrion Pharm, Inc.
Phase
Observational
Overall status
Completed
Start date
September 11, 2019
Completion date
May 25, 2023
Enrollment
718 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension